Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Exchange Rate Effect (2016 - 2025)

Northwest Biotherapeutics (NWBO) has 15 years of Exchange Rate Effect data on record, last reported at $3.1 million in Q3 2025.

  • For Q3 2025, Exchange Rate Effect rose 198.07% year-over-year to $3.1 million; the TTM value through Sep 2025 reached $1.1 million, up 133.9%, while the annual FY2024 figure was $1.3 million, 347.61% up from the prior year.
  • Exchange Rate Effect reached $3.1 million in Q3 2025 per NWBO's latest filing, up from -$3.9 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $4.7 million in Q3 2022 and bottomed at -$3.9 million in Q2 2025.
  • Average Exchange Rate Effect over 5 years is $273684.2, with a median of $236000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: surged 1509.38% in 2022, then crashed 22952.94% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at $462000.0 in 2021, then plummeted by 706.49% to -$2.8 million in 2022, then surged by 63.95% to -$1.0 million in 2023, then skyrocketed by 451.78% to $3.6 million in 2024, then dropped by 12.97% to $3.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $3.1 million in Q3 2025, -$3.9 million in Q2 2025, and -$1.6 million in Q1 2025.